MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
5.70
-0.22
-3.72%
After Hours: 5.69 -0.01 -0.11% 19:38 06/30 EDT
OPEN
5.92
PREV CLOSE
5.92
HIGH
5.97
LOW
5.62
VOLUME
4.22M
TURNOVER
--
52 WEEK HIGH
6.04
52 WEEK LOW
1.395
MARKET CAP
2.03B
P/E (TTM)
-4.6049
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PGEN last week (0622-0626)?
Weekly Report · 1d ago
Precigen: Entering The Oncology 'Sweet Spot'
Seeking Alpha · 4d ago
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance
TipRanks · 6d ago
Precigen shareholders approve 7 million-share increase to 2023 incentive plan at annual meeting
PUBT · 6d ago
Clearfield And 2 Insider Picks For Strong Growth
Simply Wall St · 6d ago
Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS Therapy - What's Changed
Simply Wall St · 06/23 13:35
Weekly Report: what happened at PGEN last week (0615-0619)?
Weekly Report · 06/22 10:39
Precigen (PGEN) Stock Could Be 79% Undervalued After FDA Exclusivity Win
Simply Wall St · 06/21 02:22
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.